Anthrax, Then and Now (cont.)
What symptoms does anthrax
cause?
Cutaneous anthrax results in a large, relatively painless, ugly skin sore
referred to as a malignant pustule. Death is rare with treatment; and 80% of
untreated patients survive as well. In the other 20%, death occurs because the
infection spreads to other parts of the body or the patients succumb to a poison
(toxin) that the bacteria produce.
Gastrointestinal anthrax is rare and appears to follow
ingestion of contaminated raw meat containing the spores. Symptoms caused by
this type of anthrax can include nausea, vomiting, abdominal pain, and diarrhea. As with
cutaneous anthrax, most people having gastrointestinal anthrax survive, with or
without antibiotic treatment.
The most dangerous form of anthrax, and the greatest
bioterrorism threat, is
inhalation anthrax. It has also been called wool sorter's disease because it
is an occupational hazard for people who sort wool. Inhaling spore-bearing dust
is the usual way that inhalation anthrax is contracted. To cause the disease,
spores must be inhaled and transported through the air passages into the tiny
air sacs (alveoli) in the lungs. The spores are then picked up by scavenger
cells (macrophages) in the lungs and are transported through small vessels (lymphatics)
to the glands (lymph nodes) in the central chest cavity (mediastinum).
In the glands, the spores transform (germinate) into active, multiplying
(reproducing) bacteria. Damage to the central chest cavity and lungs can cause
chest pain and
difficulty breathing.
From the chest, the bacteria can spread, by way of the
blood stream, to other organs (for example, the brain). Most importantly, the anthrax
bacteria anywhere in the body produce poisons (toxins) that are the primary
agents of tissue destruction, bleeding, and death. We know that the toxins are
lethal because experiments in
animals have shown that injection of the toxins alone can cause most of the
findings of the disease. Furthermore, in humans, even if antibiotics eradicate
the bacteria, some individuals still will die because the toxins remain in their
system.
As with other infectious diseases, there is a lag-time (incubation
period) between exposure to the spores and the first symptoms and signs
(manifestations) of anthrax. The incubation period is usually one to six days,
but it can be much longer, even up to several weeks. This lag time is helpful to
health-care providers during natural or terrorism-related epidemics, since it
allows time for early institution of antibiotic therapy. On the other hand, the organism may spread through the population undetected for some time. Antibiotics are quite
effective and almost always curative if used before the illness causes severe
symptoms and becomes life-threatening.
How do we diagnose
anthrax?
Most hospital laboratories should be able to make a
tentative diagnosis of anthrax. Material is collected from presumed sites of
infection: skin sores for cutaneous anthrax, stool samples for gastrointestinal anthrax, and sputum from
patients with inhalation anthrax. If the organism has spread to the nervous
system, spinal fluid may demonstrate the organism. If the anthrax bacteria have
spread throughout the body, they can be demonstrated in a blood sample. Also, it
is important to know that nasal swabs can be used to determine if someone has
been exposed to anthrax by inhalation. Finding spores in the nose, however, does
not mean that the individual has, or will develop, the disease. (Remember that
the spores have to get all the way to the lungs before damage occurs.)
To make the diagnosis of anthrax, the laboratory
personnel make slide preparations of the collected material. Then, after
applying special dyes (gram stain) to the
slide preparations, they can visualize the bacteria under the microscope.
Samples of the collected material are also transferred to special plates
containing growth media (culture plates) that enhance multiplication of the
bacterial organisms. The idea is to make more bacteria available for microscopic
and other studies. Classically, from the size and shape and the growth
characteristics of the bacteria, one can be fairly certain of the type of
bacteria causing the infection. In addition, laboratory testing of the cultured
bacteria can determine which antibiotics will be most effective in killing the
bacteria (called sensitivity testing). Finally, specialized centers, such as the
CDC, do more sophisticated genetic and molecular diagnostic studies to verify
the diagnosis of anthrax. These centers also can identify more detailed
characteristics (for example, the strain, virulence, and type of toxin) of the bacteria.
How easy is it to get an anthrax
infection?
Not very easy! Since only the spores can spread (transmit)
the disease and anthrax does not form spores in living tissues, the disease is
not transmitted from person to person. That is to say, anthrax is not
contagious. The most common way people get infected with anthrax is by working
with animal carcasses or hides that contain spores. These people usually
contract cutaneous anthrax.
Inhalation anthrax is exceedingly rare. This is because, as previously mentioned, the spores have to travel all the way to the tiny air sacs (alveoli) in the lungs. Thus, the spores must be small (less than 5 microns) and able to get past many protective barriers (such as mucus, body chemicals, and microscopic hairs) in the mouth, nose, throat, and air passages. What's more, the spores must overcome obstacles presented by the body's immune (defense) system. So, it is estimated that many thousands of spores (perhaps 10,000-20,000) are needed to establish an infection in humans. All things considered, most forms of anthrax bacteria are probably not that dangerous. Sadly, however, some governments and terrorist groups are spending millions of dollars to try to develop more deadly anthrax bacteria for use as biologic weapons. Anthrax is easy to grow. Anthrax bacteria are very resistant to destruction. Thus, when released into the air, they can spread over large distances and affect many people. It is not surprising, and it is somewhat reassuring, that major efforts are ongoing to find the best ways to prevent, detect, and treat future bioterrorist attacks using anthrax.
Last Editorial Review: 4/10/2007